Post-stroke Spasticity
Conditions
Brief summary
The aim of this study is to investigate the validity and Inter-rater reliability for early recognition of spasticity by nurses and physiotherapists using the decision tree tool.
Detailed description
The Spastic Movement Disorder (SMD) Decision Tree was designed as a tool to aid nurses, therapists and other healthcare professions recognize potential signs of disabling spasticity in the upper limb of post-stroke patients. The present study assesses validity and inter-rater reliability of the SMD Decision Tree comparing nurses and therapists with gold-standard procedure performed by rehabilitation doctors. Agreement was tested for "referral to specialist indicated" and "no referral to specialist indicated".
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Participants with a first sub-acute and chronic infarction of the middle cerebral artery / basal ganglia hemorrhage longer than four weeks after the event * Between 18-80 years old * Preserved insight and judgment capacity * Adequate language and task comprehension, attention span for 15 minutes
Exclusion criteria
* Participants with other neurological disorders * Participants who received BoNT-A treatment \< 3 months before inclusion * Reduced vigilance and attention span (less than 15 minutes) * Participants with adult representation * Participants with severe language impairment / impairment of movement and action sequences
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of the level of agreement between the nurse group and gold-standard group (trained, specialized physicians) in their decision for toxin treatment referral | Day 1-2 | Nurses use the 3 domains of the SMD Decision Tree (passive/active movement, pain) to determine potential disabling spasticity indicated for referral to a rehabilitation specialist. Specialized physicians use standard clinical procedure to detect disabling spasticity. |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of the level of agreement between the physiotherapist and/or occupational therapist group and gold-standard group (trained, specialized physicians) in their decision for toxin treatment referral | Day 1-2 |
Countries
Austria
Contacts
Merz Therapeutics